Upload Avatar (500 x 500)
Ming Lu
lum@njmu.edu.cn
Chinese, English
Jiangsu
Nanjing Medical University
Basic Medical Sciences
  • 2006-2011: PhD in Pharmacology, Nanjing Medical University
  • 2001-2006: Bachelor's in Clinical Medicine, Wannan Medical College
  • Recipient of the National Excellent Young Scientist Fund
  • Director of Jiangsu Key Laboratory of Neurodegenerative Diseases
  • 2020-present: Professor and Doctoral Supervisor, Department of Pharmacology, Nanjing Medical University
  • 2019-2020: Associate Professor and Doctoral Supervisor, Department of Pharmacology, Nanjing Medical University
  • 2015-2019: Associate Professor and Master's Supervisor, Department of Pharmacology, Nanjing Medical University
  • 2011-2015: Lecturer, Department of Pharmacology, Nanjing Medical University
  • 2007-2010: Research Assistant, Department of Pharmacology, National University of Singapore
  • 2023: Second Prize in Natural Science, Ministry of Education
  • 2023: Second Prize in Jiangsu Science and Technology Award
  • 2023: Jiangsu Province Excellent Science and Technology Innovation Team
  • 2021: First Prize in Jiangsu Higher Education Science and Technology Research
  • 2016: Second Prize in Jiangsu Education Science Research
  • 2018: Jiangsu 'Six Talent Peaks' A-Class High-Level Talent
  • 2018: Jiangsu '333 Talent Project' Third Level
  • 2013: Excellent Young Pharmacologist Award, Chinese Pharmacological Society
  • 2022: Jiangsu Youth May Fourth Medal
Neuropsychopharmacology
Mechanisms of neurodegenerative diseases
Depression pathogenesis and drug targets
  • CircEPS15, as a sponge of MIR24-3p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy., Yuanzhang Zhou, Yang Liu, Zhengwei Kang, Hang Yao, Nanshan Song, Min Wang, Chenghuan Song, Kezhong Zhang, Jianhua Ding, Juanjuan Tang, Gang Hu, Ming Lu, 2023
  • The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson's disease via LCN2-dependent astrocyte senescence., Si-Yuan Jiang, Tian Tian, Hang Yao, Xiao-Mei Xia, Cong Wang, Lei Cao, Gang Hu, Ren-Hong Du, Ming Lu, 2023
  • Impeding the combination of astrocytic ASCT2 and NLRP3 by Talniflumate alleviates neuroinflammation in experimental models of Parkinson’s disease., Yang Liu, Ting Liu, Yuanzhang Zhou, Wenjie Li, Min Wang, Nanshan Song, Wenbin Zhang, Jingwei Jiang, Shengtao Yuan, Jianhua Ding, Gang Hu, Ming Lu, 2023
  • Mefloquine targets NLRP3 to reduce lipopolysaccharide-induced systemic inflammation and neural injury., Si-Yuan Jiang, Tian Tian, Wen-Jie Li, Ting Liu, Cong Wang, Gang Hu, Ren-Hong Du, Yang Liu, Ming Lu, 2023
  • JWA binding to NCOA4 alleviates degeneration in dopaminergic neurons through suppression of ferritinophagy in Parkinson's disease., Xinxin Zhao, Zhengwei Kang, Ruixue Han, Min Wang, Yueping Wang, Xin Sun, Cong Wang, Jianwei Zhou, Lei Cao, Ming Lu, 2024
Neuropsychopharmacology Neurodegenerative Depression Drug Targets Pathogenesis Neuroinflammation Astrocytes Parkinson'S Disease Neuroprotection Molecular Mechanisms

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.